| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
18,176 | 26,692 | 31,370 | 30,834 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Stock-based compensation expense | ||||||
6,842 | 5,378 | 4,315 | 2,730 | 0 | 0 | 0 |
Depreciation and amortization | ||||||
233 | 163 | 157 | 148 | 0 | 0 | 0 |
Change in fair value of warrant liability | ||||||
- | - | - | 5,452 | 0 | 0 | 0 |
Net amortization of premiums and discounts on short-term investments | ||||||
1,443 | 1,901 | 2,030 | 1,715 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||
Research and development incentives receivable | ||||||
2,779 | 1,152 | 438 | 255 | 0 | 0 | 0 |
Prepaid expenses and other current assets | ||||||
1,732 | 1,895 | 1,428 | 801 | 0 | 0 | 0 |
Operating lease, right-of-use-asset | ||||||
0 | 0 | 0 | - | - | - | - |
Long term prepaid rent | ||||||
0 | 0 | 0 | - | - | - | - |
Accounts payable | ||||||
-1,944 | -930 | 4,143 | 120 | 0 | 0 | 0 |
Accrued expenses and other current liabilities | ||||||
2,256 | 1,794 | 302 | -292 | 0 | 0 | 0 |
Operating lease liabilities | ||||||
0 | 0 | 0 | - | - | - | - |
Deferred rent | ||||||
- | - | - | -24 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||
-55,323 | -45,691 | -32,101 | -25,378 | 0 | 0 | 0 |
Cash flows from investing activities: | ||||||
Purchases of property, plant and equipment | ||||||
7,050 | 3,627 | 2,846 | 2,600 | 0 | 0 | 0 |
Purchase of short-term investments | ||||||
174,918 | 109,709 | 197,673 | 189,931 | 0 | 0 | 0 |
Proceed from sales and maturities of short-term investments | ||||||
179,368 | 179,746 | 156,496 | 126,587 | 0 | 0 | 0 |
Net cash provided by (used in) investing activities | ||||||
-2,600 | 66,410 | -44,023 | -65,944 | 0 | 0 | 0 |
Cash flows from financing activities: | ||||||
Payment of issuance costs | ||||||
- | - | - | 2,157 | 0 | 0 | 0 |
Exercise of stock options | ||||||
0 | 0 | 0 | - | - | - | - |
Net cash provided by financing activities | ||||||
100,173 | 9,962 | 101,603 | 101,390 | 0 | 0 | 0 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
150 | -215 | -245 | -839 | 0 | 0 | 0 |
Net increase in cash, cash equivalents and restricted cash | ||||||
42,400 | 30,466 | 25,234 | 9,229 | 0 | 0 | 0 |
Supplemental disclosure of non-cash investing and financing activities: | ||||||
Net unrealized gain on short term investments | ||||||
- | - | 0 | - | - | - | - |
Deferred offering costs included in accounts payable | ||||||
- | - | - | - | - | - | 0 |
Purchases of property and equipment included in accounts payable | ||||||
- | - | - | - | - | - | 0 |
Lease assets obtained in exchange for new operating lease liabilities | ||||||
0 | 0 | 0 | - | - | - | - |